n24life

[TimAlerts] ADHD - In this trial, MDX did not meet the primary endpoint of demonstrating a statistically significant difference from placebo in the change from baseline of the investigator rating of the Conners’ Adult ADHD Rating Scales (CAARS).

TheR8Guy

[TimAlerts] ADHD - Alcobra Ltd. (ADHD) Announces Phase 3 Trial of MDX in Adults with ADHD Missed Primary Endpoint

jpd

[TimAlerts] ADHD trying to bounce back and run, but needs more volume

TriniTrader24

[TimAlerts] Been watching ADHD all this afternoon. Put a trend line on it and just didn't pull the trigger. Wanted to get in at $2.38

osirustwits

[TimAlerts] ADHD has been fliting with $2.45 all day just get over that hump and start gap filling already. Watch it gap up and run tomorrow because I wanted more confirmation

Page
of 4